Perritt Capital Management Inc Check Cap LTD Transaction History

Perritt Capital Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.31 - $0.4 $18,055 - $23,296	-58,242 Reduced 48.54%	61,758 $19,000
Q4 2021 Feb 14, 2022	BUY	$0.66 - $1.11 $40,640 - $68,349	61,576 Added 105.4%	120,000 $81,000
Q2 2021 Aug 16, 2021	SELL	$1.26 - $1.86 $63 - $93	-50 Reduced 0.09%	58,424 $75,000
Q1 2021 May 17, 2021	SELL	$1.15 - $3.07 $11,500 - $30,700	-10,000 Reduced 14.6%	58,474 $103,000
Q4 2020 Feb 16, 2021	SELL	$0.26 - $0.46 $1,709 - $3,024	-6,576 Reduced 8.76%	68,474 $31,000
Q3 2020 Nov 16, 2020	SELL	$0.32 - $0.8 $20 - $50	-63 Reduced 0.08%	75,050 $27,000
Q3 2019 Nov 12, 2019	BUY	$1.87 - $2.26 $46,750 - $56,499	25,000 Added 49.89%	75,113 $141,000
Q1 2019 May 13, 2019	BUY	$1.9 - $3.9 $95,214 - $195,440	50,113 New	50,113 $135,000

9.1K

Ticker CHEK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 116,412,000
Market Cap $105M
Description
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for d...

Get notified when there are updates to the investment portfolio of Perritt Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Perritt Capital Management Inc with notifications on news.